BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32830055)

  • 1. [Stereotaxic radiotherapy of primary extracranial tumors].
    Giraud P; Lerouge D; Latorzeff I; Mirabel X; Dohan A; Mordant P; Barry de Longchamps N
    Cancer Radiother; 2020 Oct; 24(6-7):513-522. PubMed ID: 32830055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer].
    Pouypoudat C; Trouette R; Bernard B; Vendrely V
    Cancer Radiother; 2021 Oct; 25(6-7):523-525. PubMed ID: 34454836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?].
    Kaiss H; Mornex F
    Cancer Radiother; 2019 Oct; 23(6-7):720-731. PubMed ID: 31471255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reference bases of radiotherapy under stereotaxic conditions for bronchopulmonary, hepatic, prostatic, upper aero-digestive, cerebral and bone tumors or metastases].
    Barillot I; Antoni D; Bellec J; Biau J; Giraud P; Jenny C; Lacornerie T; Lisbona A; Marchesi V; Mornex F; Supiot S; Thureau S; Noel G
    Cancer Radiother; 2018 Oct; 22(6-7):660-681. PubMed ID: 30195982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2].
    Boisselier P; Coutte A; Martin E; Pointreau Y
    Cancer Radiother; 2022 Oct; 26(6-7):755-759. PubMed ID: 36075829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiotherapy of targets in the lung and liver.
    Wulf J; Hädinger U; Oppitz U; Thiele W; Ness-Dourdoumas R; Flentje M
    Strahlenther Onkol; 2001 Dec; 177(12):645-55. PubMed ID: 11789403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer: Stereotactic body radiation therapy and surgery].
    Antoni D; Srour I; Mornex F
    Cancer Radiother; 2015 Oct; 19(6-7):371-6. PubMed ID: 26358983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New techniques and potential benefits for radiotherapy of lung cancer].
    Lefebvre L; Doré M; Giraud P
    Cancer Radiother; 2014 Oct; 18(5-6):473-9. PubMed ID: 25212504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis factors after lung stereotactic body radiotherapy for non-small cell lung carcinoma].
    Yossi S; Nguyen D; Krhili S; Lizée T; Khodri M
    Cancer Radiother; 2020 Jun; 24(3):267-274. PubMed ID: 32192839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
    Riesterer O
    Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracranial stereotaxic body irradiation: preliminary results and the Orleans hospital experience].
    Wachter T; Bouscayrol H; Champeaux E; Verrelle P; Giraud P
    Bull Cancer; 2008 Jan; 95(1):153-60. PubMed ID: 18230582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereotactic body radiotherapy for liver tumors: State of the art].
    Riou O; Azria D; Mornex F
    Cancer Radiother; 2017 Oct; 21(6-7):563-573. PubMed ID: 28888744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotactic pulmonary radiotherapy: Which machine?].
    Giraud P; Kreps S; Tournat H; Bibault JE; Fabiano E; Feutren T; Dautruche A; Durdux C
    Cancer Radiother; 2019 Oct; 23(6-7):658-661. PubMed ID: 31471252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practice changing clinical trials in radiation oncology in 2022].
    Antoni D; Claude L; Laprie A; Lévy A; Peignaux K; Rivera S; Schick U
    Cancer Radiother; 2022 Oct; 26(6-7):823-833. PubMed ID: 36055908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
    Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotactic body radiotherapy of oligometastases: Main pending trials and to come in France].
    Giraud P; Tournat H; Kreps S; Bibault JE; Dautruche A; Fabiano E; Feutren T; Durdux C
    Cancer Radiother; 2019 Oct; 23(6-7):496-499. PubMed ID: 31471251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereotactic body radiation therapy in the management of liver tumours].
    Jacob J; Nguyen F; Deutsch E; Mornex F
    Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.